overall-survival

Documents about overall-survival

• Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study#160313ClinicalTrials.gov
• Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer#1443566ClinicalTrials.gov
• PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment#979914ClinicalTrials.gov
• A Non-interventional Retrospective Study on Overall Survival in Completely Resected Chinese NSCLC Patients With Adenocarcinoma Histology- ICAN Extension Study#1010879ClinicalTrials.gov
• Prognostic Values of Hemoglobin and Red Blood Cell Distribution Width to Overall Survival in Non-Hodgkin Lymphoma#930445Acta Interna: The Journal of Internal Medicine
• Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer#873434ClinicalTrials.gov
• DataBase for Analysis of Rectal Cancer Oncological Results#307432ClinicalTrials.gov
• BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)#1282527ClinicalTrials.gov
• A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer#1475921ClinicalTrials.gov
• Determination of Immune Phenotype in Glioblastoma Patients#833548ClinicalTrials.gov
• Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series#1338729ClinicalTrials.gov
• Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.#1429506ClinicalTrials.gov
• The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real-world study on AIFA monitoring registries#185485IRIS
• Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial#1382844ClinicalTrials.gov
• A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma#1409330ClinicalTrials.gov
• Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer#848437ClinicalTrials.gov
• HP Improves Sleep and Overall Survival Rate in Maintenance Hemodialysis Patients#1231818ClinicalTrials.gov
• Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome#1139734ClinicalTrials.gov
• Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer#839444ClinicalTrials.gov
• Clinical Study on Triple Negative Breast Cancer With Chinese Medicine#1044302ClinicalTrials.gov
• Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma#1057103ClinicalTrials.gov
• Jejunoileal vs Gastric GIST in the Era of Imatinib.#857898ClinicalTrials.gov
• Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma#902132ClinicalTrials.gov
• Liver Transplantation and Uveal Malignant Melanoma#1137832ClinicalTrials.gov
• Functional gut microbiome dysbiosis is associated with overall survival after solid organ transplantation#1242650bioRxiv / medRxiv
• Usefulness of Blood Biomarkers for Overall Survival in NSCLC#1260287ClinicalTrials.gov
• Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer#4693Europe PMC
• Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment#851802ClinicalTrials.gov
• Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment#1385369ClinicalTrials.gov
• Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer#432859ClinicalTrials.gov
• The Overall Survival of Patients With Unresectable HCC in Real-life#878835ClinicalTrials.gov
• Neoadjuvant Treatment in Resectable Pancreatic Cancer#1184299ClinicalTrials.gov
• A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal Cancer#864468ClinicalTrials.gov
• Real-world Study for Patients With Advanced Hepatobiliary Tumors#1059592ClinicalTrials.gov
• Machine-Learning-Based Survival Prediction in Glioblastoma Using Graph-Theoretical Analysis of Structural Network Alterations#120134Europe PMC
• The Value of Geriatric Assessments in Older Patients With Breast Cancer#894947ClinicalTrials.gov
• Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia#1171054ClinicalTrials.gov
• Intraoperative Dexmedetomidine and Long-term Outcomes in Elderly After Major Surgery#1213861ClinicalTrials.gov
• Impact of the French ENDOCAN–COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas#213139HAL (France)
• Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy#465508PubMed Central
• Exercise and Mortality in Middle-Aged and Older Adults#897645ClinicalTrials.gov
• The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer#852788ClinicalTrials.gov
• Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics#881009ClinicalTrials.gov
• Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma#856337ClinicalTrials.gov
• Survival Prediction in Patients With Bladder Cancer Undergoing Radical Cystectomy Using a Machine Learning Algorithm: Retrospective Single-Center Study#26266HAL (France)
• International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma#872547ClinicalTrials.gov
• Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy#1252600OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma#831570ClinicalTrials.gov
• Preoperative Stereotactic Radiosurgery for Brain Metastases#1351368ClinicalTrials.gov
• Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma#208453ClinicalTrials.gov